Zivo Bioscience, Inc. (ZIVO)
3.60
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Zivo Bioscience Total Liabilities (Quarterly) : 3.826M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.826M |
| March 31, 2026 | 3.941M |
| December 31, 2025 | 4.412M |
| September 30, 2025 | 3.846M |
| June 30, 2025 | 3.244M |
| March 31, 2025 | 2.949M |
| December 31, 2024 | 2.158M |
| September 30, 2024 | 2.579M |
| June 30, 2024 | 2.871M |
| March 31, 2024 | 3.085M |
| December 31, 2023 | 2.762M |
| September 30, 2023 | 3.196M |
| June 30, 2023 | 3.855M |
| March 31, 2023 | 2.870M |
| December 31, 2022 | 2.134M |
| September 30, 2022 | 2.447M |
| June 30, 2022 | 2.854M |
| March 31, 2022 | 3.104M |
| December 31, 2021 | 2.948M |
| September 30, 2021 | 3.201M |
| June 30, 2021 | 3.771M |
| March 31, 2021 | 12.07M |
| December 31, 2020 | 11.53M |
| September 30, 2020 | 11.22M |
| June 30, 2020 | 10.22M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.327M |
| December 31, 2019 | 8.708M |
| September 30, 2019 | 10.97M |
| June 30, 2019 | 11.27M |
| March 31, 2019 | 24.80M |
| December 31, 2018 | 22.69M |
| September 30, 2018 | 21.85M |
| June 30, 2018 | 19.58M |
| March 31, 2018 | 22.35M |
| December 31, 2017 | 16.64M |
| September 30, 2017 | 19.47M |
| June 30, 2017 | 16.78M |
| March 31, 2017 | 16.57M |
| December 31, 2016 | 14.36M |
| September 30, 2016 | 13.52M |
| June 30, 2016 | 11.21M |
| March 31, 2016 | 10.47M |
| December 31, 2015 | 9.570M |
| September 30, 2015 | 8.775M |
| June 30, 2015 | 8.074M |
| March 31, 2015 | 7.540M |
| December 31, 2014 | 6.471M |
| September 30, 2014 | 9.636M |
| June 30, 2014 | 6.548M |
| March 31, 2014 | 6.667M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| PMGC Holdings, Inc. | 19.83M |
| Shonghoya Intl Group, Inc. | 0.0059M |
| Cordyceps Sunshine Biotech Holdings Co., Ltd. | -- |
| Arcadia Biosciences, Inc. | 5.26M |
| CCA Industries, Inc. | 1.176M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.4435M |
| Shareholders Equity (Quarterly) | -3.382M |
| Debt to Equity Ratio | -0.1684 |
| Current Ratio | 0.1023 |
| Net Debt Paydown Yield | 0.48% |